An examination of Alzheimer's disease case definitions using Medicare claims and survey data

Alzheimer's and Dementia

Volumn 6, Issue 4, 2010, Pages 334-341

  Lin, Pei Jung ^a   Kaufer, Daniel I ^b   MacIejewski, Matthew L ^c,d   Ganguly, Rahul ^e   Paul, John E ^f   Biddle, Andrea K ^f  

^a TUFTS MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e GLAXOSMITHKLINE   (United States)

^f IL   (United States)

Author keywords

Alzheimer's disease; Epidemiologic methods; Expenditure; Medicare; Prevalence

Indexed keywords

CHOLINESTERASE INHIBITOR; NOOTROPIC AGENT;

AGED; ALZHEIMER DISEASE; ARTICLE; DRUG COST; FEMALE; HEALTH CARE COST; HEALTH SURVEY; HUMAN; KAPPA STATISTICS; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; AGE; CLASSIFICATION; COST OF ILLNESS; ECONOMICS; HEALTH CARE POLICY; HEALTH CARE QUALITY; INSURANCE; NOMENCLATURE; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; UNITED STATES; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COST OF ILLNESS; FEMALE; HEALTH POLICY; HUMANS; INSURANCE CLAIM REVIEW; MALE; MEDICARE; MEDICARE PART A; NOOTROPIC AGENTS; QUALITY ASSURANCE, HEALTH CARE; SOCIOECONOMIC FACTORS; TERMINOLOGY AS TOPIC; UNITED STATES;

EID: 77956652458     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2009.09.001     Document Type: Article

References (34)

1. R. Katzman Alzheimer's disease N Engl J Med 314 1986 964 973 (Pubitemid 16129832)
2. D.A. Evans Estimated prevalence of Alzheimer's disease in the United States Milbank Q 68 1990 267 289
3. R. Brookmeyer, S. Gray, and C. Kawas Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset Am J Public Health 88 1998 1337 1342
4. P.D. Sloane, S. Zimmerman, C. Suchindran, P. Reed, L. Wang, and M. Boustani The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances Annu Rev Public Health 23 2002 213 231
5. US GAO Alzheimer's disease: estimates of prevalence in the US 1998 US General Accounting Office Washington, DC
6. L.E. Hebert, P.A. Scherr, J.L. Bienias, D.A. Bennett, and D.A. Evans Alzheimer disease in the US population: prevalence estimates using the 2000 census Arch Neurol 60 2003 1119 1122
7. M. Weiner, N.R. Powe, W.E. Weller, T.J. Shaffer, and G.F. Anderson Alzheimer's disease under managed care: implications from Medicare utilization and expenditure patterns J Am Geriatr Soc 46 1998 762 770 (Pubitemid 128722276)
8. D.H. Taylor Jr., and F.A. Sloan How much do persons with Alzheimer's disease cost Medicare? J Am Geriatr Soc 48 2000 639 646
9. E.M. Gutterman, J.S. Markowitz, B. Lewis, and H. Fillit Cost of Alzheimer's disease and related dementia in managed-Medicare J Am Geriatr Soc 47 1999 1065 1071
10. J.W. Hill, R. Futterman, S. Duttagupta, V. Mastey, J.R. Lloyd, and H. Fillit Alzheimer's disease and related dementias increase costs of comorbidities in managed Medicare Neurology 58 2002 62 70
11. D.A. Evans, H.H. Funkenstein, M.S. Albert, P.A. Scherr, N.R. Cook, and M.J. Chown Prevalence of Alzheimer's disease in a community population of older persons: higher than previously reported JAMA 262 1989 2551 2556
12. N. Johnson, T. Davis, and N. Bosanquet The epidemic of Alzheimer's disease: how can we manage the costs? Pharmacoeconomics 18 2000 215 223
13. D.P. Rice, H.M. Fillit, W. Max, D.S. Knopman, J.R. Lloyd, and S. Duttagupta Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective Am J Manag Care 7 2001 809 818
14. H.M. Fillit The pharmacoeconomics of Alzheimer's disease Am J Manag Care 6 2000 S1139 S1144 discussion S1145-1138
15. R. Newcomer, T. Clay, J.S. Luxenberg, and R.H. Miller Misclassification and selection bias when identifying Alzheimer's disease solely from Medicare claims records J Am Geriatr Soc 47 1999 215 219
16. H. Fillit, D.S. Geldmacher, R.T. Welter, K. Maslow, and M. Fraser Optimizing coding and reimbursement to improve management of Alzheimer's disease and related dementias J Am Geriatr Soc 50 2002 1871 1878
17. J.C. Pressley, C. Trott, M. Tang, M. Durkin, and Y. Stern Dementia in community-dwelling elderly patients: a comparison of survey data, Medicare claims, cognitive screening, reported symptoms, and activity limitations J Clin Epidemiol 56 2003 896 905
18. B.S. Bloom, N. de Pouvourville, and W.L. Straus Cost of illness of Alzheimer's disease: how useful are current estimates? Gerontologist 43 2003 158 164
19. CMS. Survey overview. 2006. Available at: www.cms.hhs.gov/apps/mcbs/ Overview.asp. Accessed November 1, 2006.
20. CMS. Appendix A: technical documentation for the Medicare Current Beneficiary Survey. 2003. Available at: www.cms.hhs.gov/mcbs/downloads/ HHC2003appendixA.pdf. Accessed October 10, 2007.
21. J. Hill, H. Fillit, S.K. Thomas, and S. Chang Functional impairment, healthcare costs and the prevalence of institutionalisation in patients with Alzheimer's disease and other dementias Pharmacoeconomics 24 2006 265 280
22. A. England, K. Hubbell, D. Judkins, and S. Ryaboy Imputation of medical cost and payment data. Proceedings of the Section on Survey Research Methods American Statistical Association 1994 406 411
23. Bureau of Labor Statistics. Consumer price index. 2007. Available at: www.bls.gov/cpi/home.htm. Accessed September 15, 2007.
24. J. Cohen A coefficient of agreement for nominal scales Educ Psychol Meas 20 1960 37 46
25. J.R. Landis, and G.G. Koch The measurement of observer agreement for categorical data Biometrics 33 1977 159 174
26. Q. McNemar Note on the sampling error of the difference between correlated proportions or percentages Psychometrika 12 1947 153 157
27. R.L. Kane, and A. Atherly Medicare expenditures associated with Alzheimer disease Alzheimer Dis Assoc Disord 14 2000 187 195
28. K. Brummel-Smith How much does it really cost to care for persons with Alzheimer's disease? J Am Geriatr Soc 49 2001 1255 1256
29. K.J. Moore Understanding Medicare's mental health treatment limitation Fam Pract Manag 7 2000 15 16
30. S.T. Farias, D. Mungas, and W. Jagust Degree of discrepancy between self and other-reported everyday functioning by cognitive status: dementia, mild cognitive impairment, and healthy elders Int J Geriatr Psychiatry 20 2005 827 834
31. M.C. Tierney, J.P. Szalai, W.G. Snow, and R.H. Fisher The prediction of Alzheimer disease: the role of patient and informant perceptions of cognitive deficits Arch Neurol 53 1996 423 427
32. K. Long, S. Sudha, and E.J. Mutran Elder-proxy agreement concerning the functional status and medical history of the older person: the impact of caregiver burden and depressive symptomatology J Am Geriatr Soc 46 1998 1103 1111
33. P.J. Neumann, S.S. Araki, and E.M. Gutterman The use of proxy respondents in studies of older adults: lessons, challenges, and opportunities J Am Geriatr Soc 48 2000 1646 1654
34. M.N. Elliott, M.K. Beckett, K. Chong, K. Hambarsoomians, and R.D. Hays How do proxy responses and proxy-assisted responses differ from what Medicare beneficiaries might have reported about their health care? Health Serv Res 43 2008 833 848